According to this market research, the sales value of Iodixanol in the Chinese market has increased from 2016 to 2020. The sales value of Iodixanol in China reached approximately CNY1.49 billion in 2020, with an increase of 1.52% YoY. The growth rate slowed down last year is because the COVID-19 epidemic causes a reduction in the number of operations in hospitals, which influences the sales of Iodixanol. The CAGR of the sales value of Iodixanol in China is 27% from 2016 to 2020.
The analyst analyzes that as the epidemic situation has been improved, sales of Iodixanol will have a recovery growth from 2021 to 2025. In addition, sales of Iodixanol will also increase due to the market expansion. According to the research, sales of contrast agents are directly related to the holding volume of CT and MRI. The holding volume in China is much less than that in developed countries. For example, the holding volume of CT for a million people in China is 1/2 of that in the U.S., and 1/5 of that in Japan. Therefore, the number of equipment still has the potential to increase, which will lead the contrast agent market to expand. Iodixanol, as one of the most popular contrast agents, will continue to grow in the short term.
- The impact of COVID-19 on China's Iodixanol market
- Sales value and volume of China's Iodixanol 2016-2020
- Competitive landscape of China's Iodixanol market
- Prices of Iodixanol in China
- Prices of Iodixanol in China by regions and manufacturers
- Analysis of factors affecting the development of China's Iodixanol market
- Prospect of China's Iodixanol market from 2021 to 2025
What is the estimated value of the Chinese Iodixanol Market?
What is the growth rate of the Chinese Iodixanol Market?
What is the forecasted size of the Chinese Iodixanol Market?
Who are the key companies in the Chinese Iodixanol Market?
Table of Contents
1.2 Development of Iodixanol in China
1.3 Governmental Approval of Iodixanol in China
1.4 The Impact of COVID-19 on Iodixanol sales in China
2.1.1 Overall Sales Value
2.1.2 Sales Value by Region
2.2 Sales Volume of Iodixanol
2.2.1 Overall Sales Volume
2.2.2 Sales Volume by Region
2.3 Sales of Iodixanol by Dosage Form in China, 2016-2020
2.3.2 Analysis of Other Dosage Forms
3.1.1 Investigation on Market Share by Sales Value
3.1.2 Investigation on Market Share by Sales volume
3.2 Jiangsu Hengrui Medicine Co., Ltd.
3.2.1 Enterprise Profile
3.2.2 Sales of Huiyu (Jiangsu Hengrui's Iodixanol) in China
3.3 GE Healthcare AS
3.3.1 Enterprise Profile
3.3.2 Sales of VISIPAQUE (GE Healthcare's Iodixanol) in China
3.4 Yangtze River Pharmaceutical Group
3.4.1 Enterprise Profile
3.4.2 Sales of Xiansu (Yangtze River's Iodixanol) in China
3.5 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd.
3.5.1 Enterprise Profile
3.5.2 Sales of Qingliming (Nanjing CTTQ's Iodixanol) in China
3.6 Beijing Beilu Pharmaceutical Co., Ltd.
3.6.1 Enterprise Profile
3.6.2 Sales of Dianchunning (Beijing Beilu's Iodixanol) in China
4.2 GE Healthcare AS (VISIPAQUE)
4.3 Yangtze River Pharmaceutical Group (Xiansu)
4.4 Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. (Qingliming)
4.5 Beijing Beilu Pharmaceutical Co., Ltd. (Dianchunning)
5.1.1 The Impact of COVID-19 on Chinese Iodixanol Market
5.1.2 Market Drivers and Opportunities
5.1.3 Market Threats and Challenges
5.2 Forecast on Market Size
5.3 Forecast on Market Trend
Chart Sales Value of Iodixanol Injection over the World
Chart Sales Value of Iodixanol Injection in China, 2016-2020
Chart Sales Value of Iodixanol Injection in China by Regions, 2016-2020
Chart Sales Volume of Iodixanol Injection in China, 2016-2020
Chart Sales Volume of Iodixanol Injection in China by Regions, 2016-2020
Chart Market Share by Sales Value of Top Iodixanol Manufacturers in China, 2016-2020
Chart Sales Value and Volume of Jiangsu Hengrui's Iodixanol in China, 2016-2020
Chart Sales Value and Volume of VISIPAQUE in China, 2016-2020
Chart Sales Value and Volume of Xiansu in China, 2016-2020
Chart Sales Value and Volume of Qingliming, 2016-2020
Chart Sales Value and Volume of Dianchunning, 2016-2020
Chart Referential Prices of Jiangsu Hengrui's Iodixanol in China, 2020-2021
Chart Referential Prices of VISIPAQUE in China, 2020-2021
Chart Referential Prices of Xiansu in China, 2020-2021
Chart Referential Prices of Qingliming in China, 2020-2021
Chart Referential Prices Dianchunning in China, 2020-2021
Chart Forecast on Sales Value of Iodixanol in China, 2021-2025
Chart Forecast on Sales Volume of Iodixanol in China, 2021-2025
- Beijing Beilu Pharmaceutical
- GE Healthcare
- Jiangsu Hengrui Medicine
- Nanjing Chia Tai Tianqing Pharmaceutical
- Yangtze River Pharmaceutical
Background research defines the range of products and industries, which proposes the key points of the research. Proper classification will help clients understand the industry and products in the report.
Secondhand material research is a necessary way to push the project into fast progress. The analyst always chooses the data source carefully. Most secondhand data they quote is sourced from an authority in a specific industry or public data source from governments, industrial associations, etc. For some new or niche fields, they also "double-check" data sources and logics before they show them to clients.
Primary research is the key to solve questions, which largely influence the research outputs. The analyst may use methods like mathematics, logical reasoning, scenario thinking, to confirm key data and make the data credible.
The data model is an important analysis method. Calculating through data models with different factors weights can guarantee the outputs objective.
The analyst optimizes the following methods and steps in executing research projects and also forms many special information gathering and processing methods.
1. Analyze the life cycle of the industry to understand the development phase and space.
2. Grasp the key indexes evaluating the market to position clients in the market and formulate development plans
3. Economic, political, social and cultural factors
4. Competitors like a mirror that reflects the overall market and also market differences.
5. Inside and outside the industry, upstream and downstream of the industry chain, show inner competitions
6. Proper estimation of the future is good guidance for strategic planning.